/
/
/

Gland Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)3,161.60
Volume (₹)16,384.00
High (₹)3,170.00
Upper Circuit3,790.60
Low (₹)3,124.50
Lower Circuit2,527.20
Prev Close3,158.90
52W High (₹)3,171.00
Price3,135.30
52W Low (₹)1,573.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)52147.60 Cr
Div. Yield (%)0.63
PE Ratio46.20
Debt to Equity0.02
Price to Book2.71
Book Value625.91
EPS (TTM)68.41
Face Value1.00
ROE (%)10.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
GLANDNSE
LTP
1W Low
1W High
Market cap (₹)
1788.1+10.4 (0.59%)
1722
1796.60
4,25,150Cr
9993+213 (2.18%)
9863
10067
2,66,265Cr
4650.1+36.7 (0.80%)
4553
4675
1,76,301Cr
2317.8-87.7 (-3.65%)
2252.40
2441.90
1,25,352Cr
1259.4+13.9 (1.12%)
1217.20
1261
1,23,591Cr
1372.3+20.3 (1.50%)
1336.70
1376.70
1,14,351Cr
1393.4+14.5 (1.05%)
1364.60
1400.80
1,12,474Cr
2498.5+5.7 (0.23%)
2457.90
2512.30
1,02,315Cr
1699+17.6 (1.05%)
1656.20
1708.80
97,757Cr
2028.8+17.8 (0.89%)
1988.90
2062.10
92,007Cr
3135.3+39.4 (1.27%)
3035
3170
52,148Cr

Key Highlights of Gland Pharma Ltd Balance Sheet

Gland Pharma Ltd balance sheet discloses shareholders' funds of ₹16.48Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹16.48Cr, and the reserves and surplus of the company is ₹10748Cr.

The company has its non-current liabilities with total liabilities of ₹11607.2Cr as of 2026-03-31.

The current liabilities are ₹633.02Cr as of 2026-03-31. At the same time, current assets are ₹6422.22Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹3292.55Cr and tangible assets of ₹1688.43Cr, provided in the Gland Pharma Ltd financial statements.